Gender Differences in Prevalence of Undiagnosed Diabetes in ACS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Yale University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
American Heart Association
Ethel F Donaghue Women's Health Investigator's Program at Yale
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00589459
First received: December 27, 2007
Last updated: January 8, 2008
Last verified: December 2007

December 27, 2007
January 8, 2008
October 2001
September 2005   (final data collection date for primary outcome measure)
Prevalence of undiagnosed pre-diabetes or undiagnosed diabetes [ Time Frame: after hospitalization for acute coronary syndrome ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00589459 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
A Pilot Study of Gender Differences in the Prevalence of Undiagnosed Diabetes in Acute Coronary Syndromes (ACS)

The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Unit 6-8 weeks after hospital discharge for an oral glucose tolerance test to identify individuals with pre-diabetes and diabetes.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Probability Sample

Women and men admitted with an acute coronary syndrome who do not have a prior diagnosis of diabetes

  • Pre-Diabetes
  • Diabetes
Not Provided
  • 1
    non-diabetic women with acute coronary syndrome (ACS)
  • 2
    non-diabetic men with acute coronary syndrome (ACS)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
103
December 2008
September 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • acute coronary syndrome
  • age > 30 yrs

Exclusion Criteria:

  • previously diagnosed diabetes
  • ACS due to substance abuse or trauma
Both
30 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00589459
12258, AHA, Donaghue Women's Health R02524
No
Barbara I Gulanski, MD, MPH, Yale University School of Medicine
Yale University
  • American Heart Association
  • Ethel F Donaghue Women's Health Investigator's Program at Yale
Principal Investigator: Barbara I Gulanski, MD, MPH Yale University
Yale University
December 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP